Targeted regional injection of biocomposite microspheres alters post-myocardial infarction remodeling and matrix proteolytic pathways

Circulation

Volumn 124, Issue 11 SUPPL. 1, 2011, Pages

  Dixon, Jennifer A ^a   Gorman, Robert C ^c   Stroud, Robert E ^a   Mukherjee, Rupak ^a   Meyer, Evan C ^a   Baker, Nathaniel L ^b   Morita, Masato ^c   Hamamoto, Hirotsugu ^c   Ryan, Liam P ^c   Gorman, Joseph H ^c   Spinale, Francis G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

infarct expansion; matrix metalloproteinase; tissue inhibitor of matrix metalloproteinases

Indexed keywords

COLLAGEN; COLLAGENASE 3; GELATINASE A; GELATINASE B; HYDROXYAPATITE; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MICROSPHERE; NEUTROPHIL COLLAGENASE; SODIUM CHLORIDE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPOSITE MATERIAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ANIMALS; COLLAGEN; DURAPATITE; EXTRACELLULAR MATRIX; INJECTIONS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASES; MICROSPHERES; MODELS, ANIMAL; MYOCARDIAL INFARCTION; SHEEP; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASES; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 80052746571     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.035774     Document Type: Article

References (41)

1. Jackson BM, Gorman JH, Moainie SL, Guy TS, Narula N, Narula J, John-Sutton MG, Edmunds LH Jr, Gorman RC. Extension of borderzone myocardium in postinfarction dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:1160-1171.
2. Gupta KB, Ratcliffe MB, Fallert MA, Edmunds LH Jr, Bogen DK. Changes in passive mechanical stiffness of myocardial tissue with aneurysm formation. Circulation. 1994;89:2315-2326. (Pubitemid 24142813)
3. Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiol Rev. 2007;87: 1285-1342. (Pubitemid 350041472)
4. Vanhoutte D, Schellings M, Pinto Y, Heymans S. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc Res. 2006;69:604-613. (Pubitemid 43139724)
5. Mukherjee R, Brinsa TA, Dowdy KB, Scott AA, Baskin JM, Deschamps AM, Lowry AS, Escobar GP, Lucas DG, Yarbrough WM, Zile MR, Spinale FG. Myocardial infarct expansion and matrix metalloproteinase inhibition. Circulation. 2003;107:618-625. (Pubitemid 36176814)
6. Spinale FG, Mukherjee R, Zavadzkas JA, Koval CN, Bouges S, Stroud RE, Dobrucki LW, Sinusas AJ. Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction. J Biol Chem. 2010;285: 30316-30327.
7. Ruddy JM, Jones JA, Stroud RE, Mukherjee R, Spinale FG, Ikonomidis JS. Differential effects of mechanical and biological stimuli on matrix metalloproteinase promoter activation in the thoracic aorta. Circulation. 2009;120:S262-S268.
8. Charoonpatrapong-Panyayong K, Shah R, Yang J, Alvarez M, Pavalko FM, Gerard-O'Riley R, Robling AG, Templeton E, Bidwell JP. Nmp4/ciz contributes to fluid shear stress induced mmp-13 gene induction in osteoblasts. J Cell Biochem. 2007;102:1202-1213. (Pubitemid 350220041)
9. Wang TL, Yang YH, Chang H, Hung CR. Angiotensin II signals mechanical stretch-induced cardiac matrix metalloproteinase expression via Jak-Stat pathway. J Mol Cell Cardiol. 2004;37:785-794. (Pubitemid 39194570)
10. Ross JJ. Mechanical consequences of regional myocardial ischemia. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. New York, NY: Raven Press; 1991: 1997-2014.
11. Lieberman AN, Weiss JL, Jugdutt BI, Becker LC, Bulkley BH, Garrison JG, Hutchins GM, Kallman CA, Weisfeldt ML. Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog. Circulation. 1981;63:739-746. (Pubitemid 11146883)
12. Wilson EM, Moainie SL, Baskin JM, Lowry AS, Deschamps AM, Mukherjee R, Guy TS, St John-Sutton MG, Gorman JH III, Edmunds LH Jr, Gorman RC, Spinale FG. Region-and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling. Circulation. 2003;107:2857-2863. (Pubitemid 36705998)
13. Dixon JA, Gaillard WF, II, Rivers WT, Koval CN, Stroud RE, Mukherjee R, Spinale FG. Heterogeneity in mt1-mmp activity with ischemiareperfusion and previous myocardial infarction: relation to regional myocardial function. Am J Physiol Heart Circ Physiol. 2010;299: H1947-H1958.
14. Pilla JJ, Blom AS, Gorman JH III, Brockman DJ, Affuso J, Parish LM, Sakamoto H, Jackson BM, Acker MA, Gorman RC. Early postinfarction ventricular restraint improves borderzone wall thickening dynamics during remodeling. Ann Thorac Surg. 2005;80:2257-2262. (Pubitemid 41718068)
15. Enomoto Y, Gorman JH III, Moainie SL, Jackson BM, Parish LM, Plappert T, Zeeshan A, St John-Sutton MG, Gorman RC. Early ventricular restraint after myocardial infarction: extent of the wrap determines the outcome of remodeling. Ann Thorac Surg. 2005;79:881-887. (Pubitemid 40288741)
16. Kelley ST, Malekan R, Gorman JH III, Jackson BM, Gorman RC, Suzuki Y, Plappert T, Bogen DK, Sutton MG, Edmunds LH Jr. Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction. Circulation. 1999;99:135-142. (Pubitemid 29035968)
17. Cheng A, Nguyen TC, Malinowski M, Langer F, Liang D, Daughters GT, Ingels NB Jr, Miller DC. Passive ventricular constraint prevents transmural shear strain progression in left ventricle remodeling. Circulation. 2006;114: I79-I86. (Pubitemid 44297133)
18. Blom AS, Pilla JJ, Gorman RC III, Gorman JH, Mukherjee R, Spinale FG, Acker MA. Infarct size reduction and attenuation of global left ventricular remodeling with the Corcap cardiac support device following acute myocardial infarction in sheep. Heart Fail Rev. 2005;10:125-139. (Pubitemid 41662411)
19. Ryan LP, Matsuzaki K, Noma M, Jackson BM, Eperjesi TJ, Plappert TJ, St John-Sutton MG, Gorman JH III, Gorman RC. Dermal filler injection: a novel approach for limiting infarct expansion. Ann Thorac Surg. 2009; 87:148-155.
20. Mukherjee R, Zavadzkas JA, Saunders SM, McLean JE, Jeffords LB, Beck C, Stroud RE, Leone AM, Koval CN, Rivers WT, Basu S, Sheehy A, Michal G, Spinale FG. Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs. Ann Thorac Surg. 2008;86:1268-1276.
21. Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, Goldberg AT, Zellner JL, Crumbley AJ. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 2000;102: 1944-1949.
22. Spinale FG, Koval CN, Deschamps AM, Stroud RE, Ikonomidis JS. Dynamic changes in matrix metalloproteinase activity within the human myocardial interstitium during myocardial arrest and reperfusion. Circulation. 2008;118:S16-S23.
23. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res. 2010;106:1675-1680.
24. Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. TGF-beta signaling in vascular fibrosis. Cardiovasc Res. 2007;74: 196-206.
25. Spruill LS, Lowry AS, Stroud RE, Squires CE, Mains IM, Flack EC, Beck C, Ikonomidis JS, Crumbley AJ, McDermott PJ, Spinale FG. Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy. Am J Physiol Cell Physiol. 2007;293:C1362-C1373. (Pubitemid 47556744)
26. Bumham KP, Anderson DR. Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach. New York: Springer-Verlag; 2002.
27. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125: 279-284. (Pubitemid 33000466)
28. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol. 2010;7:30-37.
29. Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther. 2009;123:255-278.
30. Poller W, Hajjar R, Schultheiss HP, Fechner H. Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure. Cardiovasc Res. 2010;86:353-364.
31. Wollert KC, Drexler H. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol. 2010;7:204-215.
32. Hao X, Silva EA, Mansson-Broberg A, Grinnemo KH, Siddiqui AJ, Dellgren G, Wardell E, Brodin LA, Mooney DJ, Sylven C. Angiogenic effects of sequential release of VEGF-a165 and PDGF-bb with alginate hydrogels after myocardial infarction. Cardiovasc Res. 2007;75: 178-185. (Pubitemid 46876668)
33. Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 2004;10:403-409. (Pubitemid 38580261)
34. Dai W, Wold LE, Dow JS, Kloner RA. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol. 2005;46:714-719. (Pubitemid 41132703)
35. Selvamurugan N, Partridge NC. Constitutive expression and regulation of collagenase-3 in human breast cancer cells. Mol Cell Biol Res Commun. 2000;3:218-223. (Pubitemid 30602027)
36. Lindsey ML, Escobar GP, Mukherjee R, Goshorn DK, Sheats NJ, Bruce JA, Mains IM, Hendrick JK, Hewett KW, Gourdie RG, Matrisian LM, Spinale FG. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation. 2006;113:2919-2928. (Pubitemid 44297233)
37. Divakaran V, Mann DL. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res. 2008;103:1072-1083.
38. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P, Maessen JG, Heymans S, Pinto YM, Creemers EE. Mir-133 and mir-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res. 2009;104:170-178.
39. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN. Dysregulation of microRNAs after myocardial infarction reveals a role of mir-29 in cardiac fibrosis. Proc Natl Acad Sci USA. 2008;105:13027-13032.
40. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107:677-684.
41. O'Callaghan CJ, Williams B. Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells: role of TGFbeta( 1). Hypertension. 2000;36:319-324.